Pharmaceutical Drugs Global Market Report 2018

1
PharwaÐeutiÐal Drugs Glodal Market Report ???8
Including MusÐuloskeletal Disorders Drugs
CardioasÐular Drugs OYÐology Drugs
AYti-iYfeÐtie Drugs MetadoliÐ Disorders Drugs
CeYtral Nerous Systew Drugs GeYito-uriYary
Drugs Respiratory Diseases Drugs
GastroiYtestiYal Drugs Hewatology Drugs
Derwatology Drugs Ophthalwology Drugs
Covering Noartis AG, SaYofi S.A, F. HoffwaYY-La
RoÐhe Ltd., Pfizer IYÐ., Gilead SÐieYÐes IYÐ.
Fed ???8
2

• Reasons to Purchase
• Outperform competitors using accurate up to date
  demand-side dynamics information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of
  historic and forecast data and the drivers and
  restraints on the market.
• Create regional and country strategies on the
  basis of local data and analysis.
• Stay abreast of the latest customer and market
  research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future
  developments.
• Utilize the relationships between key data sets
  for superior strategizing.
• Suitable for supporting your internal and
  external presentations with reliable high quality
  data and analysis
• Gain a global perspective on the development of
  the market.
• Report will be updated with the latest data and
  delivered to you within 3-5 working days of
  order.
• Scope
• Markets Covered Musculoskeletal Disorders Drugs
  Cardiovascular Drugs Oncology Drugs
  Anti-infective Drugs Metabolic Disorders Drugs
  Central Nervous System Drugs Genito-urinary
  Drugs Respiratory Diseases Drugs
  Gastrointestinal Drugs Hematology Drugs
  Dermatology Drugs Ophthalmology Drugs.
• Companies Mentioned Novartis AG, Sanofi S.A, F.
  Hoffmann-La Roche Ltd., Pfizer Inc., Gilead
  Sciences Inc.
• Countries Brazil, China, France, Germany, India,
  Italy, Japan, Spain, Russia, UK, USA and
  Australia.
• Regions Asia-Pacific, Western Europe, Eastern
  Europe, North America, South America, Middle East
  And Africa

3
Pharmaceutical Drugs Market Characteristics

• The pharmaceutical industry develops drugs to
  diagnose, cure, treat or prevent diseases.
  Pharmaceutical companies produce both generic
  and branded drugs. Pharmaceutical drugs are
  subjected to various laws and regulations that
  deal with patenting, testing, safety, efficacy
  and marketing.
• Pharmaceutical companies produce
  pharmaceutical drugs made from active
  pharmaceutical ingredients (API) and excipients.
• Pharmaceutical preparations are drugs
  intended for human or veterinary use
  presented in their finished dosage form.
  Companies engaged in pharmaceutical preparations
  are involved in drug discovery and development,
  manufacturing, drug processing and sales and
  marketing of drugs for human or veterinary use.
  Tablets, ampoules, capsules, ointments and
  medicinal powders and solutions are the
  various pharmaceutical preparations produced by
  pharmaceutical companies.
• The pharmaceutical drugs market is segmented as
  follows
• Musculoskeletal Disorders Drugs market comprises
  companies that
• Cardiovascular Drugs market covers the drugs used
  to treat conditions that affect the heart or
• Oncology Drugs prevent the growth of malignant
  tumors by affecting the process of cell division
  or by
• Anti-infective Drugs are used to treat infectious
  diseases caused by several pathogenic organisms
  such as
• Metabolic Disorder Drugs market covers
  medications that are used in the

4
Central Nervous System Drugs market includes
drugs that are used for the treatment of
a Genito-urinary Drugs market covers drugs that
are used in the treatment of diseases such
as Respiratory Drugs market covers drugs that
are used in the treatment of a wide range
of Gastrointestinal Drugs market covers
medicines used for the treatment of ulcerative
colitis, diverticular disease, perianal
infections, and Hematology Drugs market offers
drugs, blood and blood products that are used for
the Dermatology Drugs market includes
medications that are used for the treatment of
skin conditions such as Ophthalmology Drugs
market covers drugs that are used in In this
report market value is defined as the revenues
organizations earn by selling their goods and
services within the specified market, based on
the price at which they sell. Only goods and
services traded between entities are
included. The revenues for a specified geography
are consumption values that is, they are
revenues generated by organizations in the
specified geography within the specified
market, irrespective of where they are produced.
5
Pharmaceutical Drugs Market Historic Growth
The global pharmaceutical drugs market grew from
X billion in 2013 to X billion in 2017 at a
compound annual growth rate (CAGR) of X. The
chart and table below shows the
year-on-year growth of the global
pharmaceutical drugs market during 2013 2017.
Drivers of the Market Restraints on the Market
6
Pharmaceutical Drugs Market Forecast Growth
The global pharmaceutical drugs market is
expected to grow from XX billion in 2017 to
1,170 billion in 2021 at a compound annual
growth rate (CAGR) of XX. The chart and
table below shows the year-on-year
growth of the global pharmaceutical drugs
market during 2017 - 2021.
Drivers of the Market Restraints on the Market
7
Pharmaceutical Drugs Market Segmentation
The chart and table below shows the split of the
pharmaceutical drugs market in 2017.
8
The total market value for pharmaceutical drugs
was X billion in 2017. The markets that are
covered include Musculoskeletal Disorders Drugs
Cardiovascular Drugs Oncology Drugs
Anti-infective Drugs Metabolic Disorders Drugs
Central Nervous System Drugs Genito-urinary
Drugs Respiratory Diseases Drugs
Gastrointestinal Drugs Hematology Drugs
Dermatology Drugs Ophthalmology
Drugs. Musculoskeletal Disorders Drugs was the X
largest segment in the pharmaceutical drugs
market with X share of the market.
The market value for the musculoskeletal
disorders drugs was X billion in
2017. Cardiovascular Drugs made up around X
share of the market. The market value for the
cardiovascular drugs was X billion in 2017.
9
Pharmaceutical Drugs Market Regional And Country
Analysis
The Asia Pacific was the largest region in the
pharmaceutical drugs market in 2017,
pharmaceutical drugs for X billion or X market
share. North America was the x largest region
pharmaceutical drugs for X billion or X market
share. Western Europe was the x largest region
pharmaceutical drugs for X billion or X market
share.
10
Pharmaceutical Drugs Market Competitive Landscape
The leading competitors in the global
pharmaceutical drugs market are Novartis AG,
Sanofi S.A, F. Hoffmann-La Roche Ltd., Pfizer
Inc., Gilead Sciences Inc. The chart and table
below displays the percentage market share of the
top players in the pharmaceutical drugs market
industry.
Novartis AG generated revenues of XX billion for
the financial year 2016, an XX decrease from the
previous year. Sanofi S.A. generated revenues of
XX billion for the financial year 2016, an XX
decrease from the previous year. F. Hoffmann-La
Roche Ltd. generated revenues of XX billion for
the financial year 2016, an XX increase from the
previous year. Pfizer Inc. generated revenues of
XX billion for the financial year 2016, an XX
increase from the previous year.
11
Gilead Sciences, Inc. generated revenues of XX
billion for the financial year 2016, an XX
decrease from the previous year. Johnson
Johnson generated revenues of XX billion for the
financial year 2016, an XX increase from the
previous year. GlaxosmithKline Plc. generated
revenues of XX billion for the financial year
2016, an XX increase from the previous
year. Bayer AG generated revenues of XX billion
for the financial year 2016, an XX decrease from
the previous year. Teva Pharmaceuticals generated
revenues of XX billion for the financial year
2016, an XX increase from the previous
year. Merck Co. generated revenues of XX
billion for the financial year 2016, an XX
decrease from the previous year.Company
Profile Novartis AG Overview Novartis AG was the
largest competitor in the pharmaceutical drugs
market in 2017 with a XX share of the
market. Novartis is a multinational
pharmaceutical company that develops,
manufacture and markets healthcare
products. The company was founded in
1970 and is headquartered in Basel,
Switzerland. Products and Services The company
operates through the following divisions The
Innovative Medicines division focuses on
ophthalmology, neuroscience, immunology and The
Alcon division focuses on the The Sandoz
division focuses on biopharmaceuticals,
12
Strategy Noartis gro?th strategy is to
foÐus oY streYgtheYiYg its ophthalwology pipel
ine through acquisitions. In December 2016,
the company acquired pharmaceutical company
Encore Vision, Inc. that develops treatment
for presbyopia, an ophthalmologic disorder. In
addition, Novartis is focusing on licensing new
products to Financial Performance Novartis
generated revenues of XX billion for the
financial year 2016, a XX decrease from the
previous year. The company had a market
Sanofi S.A Overview Products and Services
Strategy Financial Performance F. Hoffmann-La
Roche Ltd. Overview Products and Services
Strategy Financial Performance Pfizer
Inc. Overview Products and Services
Strategy Financial Performance Gilead Sciences
Inc. Overview Products and Services
Strategy Financial Performance